IRIS
FREDIANI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.504
EU - Europa 26.000
AS - Asia 14.017
SA - Sud America 3.054
AF - Africa 427
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 1
Totale 72.071
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.079
RU - Federazione Russa 6.230
GB - Regno Unito 5.573
SG - Singapore 4.823
CN - Cina 4.613
IT - Italia 4.163
IE - Irlanda 2.866
BR - Brasile 2.612
DE - Germania 1.555
SE - Svezia 1.455
UA - Ucraina 1.302
HK - Hong Kong 1.187
FR - Francia 1.007
KR - Corea 955
VN - Vietnam 842
FI - Finlandia 764
IN - India 465
NL - Olanda 233
CA - Canada 224
AR - Argentina 162
TR - Turchia 161
ES - Italia 156
BD - Bangladesh 140
PL - Polonia 138
MX - Messico 131
CI - Costa d'Avorio 130
JP - Giappone 127
IQ - Iraq 107
CZ - Repubblica Ceca 102
ZA - Sudafrica 101
AT - Austria 93
EC - Ecuador 83
PK - Pakistan 79
ID - Indonesia 61
BE - Belgio 58
UZ - Uzbekistan 57
MA - Marocco 56
IR - Iran 54
SA - Arabia Saudita 45
AU - Australia 43
CL - Cile 37
LT - Lituania 37
VE - Venezuela 37
AE - Emirati Arabi Uniti 36
CH - Svizzera 36
KE - Kenya 35
CO - Colombia 32
PY - Paraguay 31
GR - Grecia 30
RO - Romania 29
JO - Giordania 27
PE - Perù 26
IL - Israele 24
UY - Uruguay 23
PH - Filippine 22
TN - Tunisia 22
EG - Egitto 21
AZ - Azerbaigian 20
JM - Giamaica 18
PT - Portogallo 18
DK - Danimarca 17
BY - Bielorussia 16
KZ - Kazakistan 16
BG - Bulgaria 15
EE - Estonia 15
EU - Europa 15
NP - Nepal 15
LV - Lettonia 14
MY - Malesia 14
AL - Albania 12
DZ - Algeria 12
KG - Kirghizistan 12
TW - Taiwan 12
AM - Armenia 11
LB - Libano 11
OM - Oman 11
DO - Repubblica Dominicana 10
PA - Panama 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
HU - Ungheria 9
PS - Palestinian Territory 9
CY - Cipro 8
ET - Etiopia 8
RS - Serbia 8
HN - Honduras 7
MG - Madagascar 7
MK - Macedonia 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
BH - Bahrain 6
BO - Bolivia 6
CR - Costa Rica 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
LK - Sri Lanka 6
LY - Libia 6
TH - Thailandia 6
GY - Guiana 5
HR - Croazia 5
Totale 71.986
Salva come PNG Salva come JPEG
Città #
Dallas 6.225
Southend 4.898
Singapore 3.131
Dublin 2.822
Fairfield 2.342
Ashburn 2.159
Moscow 1.716
Santa Clara 1.524
Chandler 1.388
Woodbridge 1.197
Hong Kong 1.157
Hefei 1.117
Beijing 1.078
Jacksonville 990
Wilmington 952
Seoul 950
Houston 871
Seattle 846
Cambridge 797
Siena 765
Menlo Park 720
Ann Arbor 651
Munich 512
Milan 486
Los Angeles 474
Princeton 463
New York 441
Helsinki 372
Nanjing 318
The Dalles 267
São Paulo 258
Rome 250
Ho Chi Minh City 225
Florence 221
Bengaluru 208
San Mateo 199
Boardman 198
Buffalo 184
Hanoi 170
San Diego 155
Redondo Beach 145
Council Bluffs 142
Abidjan 130
Dearborn 130
Chicago 129
Shanghai 126
Columbus 125
London 117
Dong Ket 114
Nanchang 110
Turku 109
Warsaw 107
Düsseldorf 104
Lappeenranta 97
Tokyo 92
Shenyang 87
Nuremberg 82
Denver 80
Lancaster 80
Rio de Janeiro 78
Stockholm 77
Guangzhou 76
Lauterbourg 76
Montreal 75
Málaga 74
Brooklyn 73
Orem 66
Atlanta 65
Hebei 63
San Francisco 63
Toronto 63
Belo Horizonte 62
Tianjin 61
Washington 61
Poplar 57
Boston 56
Chennai 56
Vienna 56
Changsha 55
Jiaxing 55
Olomouc 55
Frankfurt am Main 54
Fremont 54
Portsmouth 54
Izmir 53
Jinan 53
Johannesburg 53
Phoenix 52
Brussels 51
Mexico City 50
Naples 49
Tashkent 49
Haiphong 43
Norwalk 43
Bologna 41
Brasília 41
Kunming 40
Turin 40
San Jose 39
Baghdad 38
Totale 48.123
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 804
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 548
A first update on mapping the human genetic architecture of COVID-19 541
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 461
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 458
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 454
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 377
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 356
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 345
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 333
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography 333
Genetic mechanisms of critical illness in COVID-19 333
Antirheumatic agents in covid-19: is IL-6 the right target? 332
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 331
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 330
AB0969 Accuracy of blind intra-articular injections in patients with osteoarthritis of the knee. An ultrasonography controlled study 330
An explainable model of host genetic interactions linked to COVID-19 severity 327
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 324
AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis 321
Angiogenesis in alkaptonuria 301
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 300
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 300
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 299
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 298
Bone mineral density in patients with systemic sclerosis. 297
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 296
Peripheral biomarkers' panel for severe COVID-19 patients 292
Long-term effects of neridronate on human osteoblastic cell cultures 290
Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: The axial scan of the meniscus 289
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 288
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 288
Deltoideal acromial enthesopathy in ankylosing spondylitis and in spondylarthropathies: comment on the article by Lambert et al. 284
AB1308 Prevalence of baker’s CYST in patients with chronic gonalgia and relationship with major non inflammatory diseases 284
Spasmophilia and entrapment nerve syndrome comorbidities in fibromyalgic patients: a possible neuromuscular pain generator. 283
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 281
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 279
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 277
Pathogen-sugar interactions revealed by universal saturation transfer analysis 274
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 273
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 269
Mapping the human genetic architecture of COVID-19 267
Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound 265
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 265
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 263
Radiologists and rheumatologists on performing and reporting shoulder ultrasound: From disagreement to consensus 263
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 262
FRI0501 Ultrasound versus synovial fluid analysis for the diagnosis of calcium pyrophosphate dihydrate deposition disease: preliminary results 262
Ultrasonography and magnetic resonance imaging of heel fat pad inflammatory-oedematous lesions in rheumatoid arthritis 260
A proteomic study of human osteoblastic cells proliferation and differentiation 260
Ultrasound in the diagnosis of calcium pyrophosphate dihydrate deposition disease. A systematic literature review and a meta-analysis 259
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 258
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. 257
A randomized comparison of the acceleraded folinic acid and 5-fluorouracil versus the conventional 5-fluorouracil schedule in advanced colorectal cancer. Supportive care and quality of life. 255
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 253
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 249
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 246
SAT0312 Ultrasound Reliability in the Diagnosis of Calcium Pyrophosphate Deposition Disease: Agreement Between Observers and Main Causes of Discordance 245
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 243
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 242
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 241
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 241
Sonographic and electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. 241
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 240
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 240
Efficacy of extracorporeal shock wave treatment in calcaneal enthesophytosis. 238
FRI0533 Ultrasonographic Features of Joints and Entheses in Healty Children 236
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 235
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 231
Weekly oral alendronate in mevalonate kinase deficiency 230
Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk 228
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 227
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)] 227
Extracorporeal shock wave therapy in the treatment of inferior calcaneal enthesophytosis: outcome by fan-beam dual x ray absorptiometry (DXA). 226
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 226
Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: An ultrasonographic study 226
Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation 223
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 222
SAT0530 The Useful of us in Diagnosis of Carpal Tunnel Syndrome in Diabetics: a Proposal for New Reference Values 221
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 221
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 221
SAT0315 Calcium Pyrophosphate Dihydrate Deposition Disease: A Proposal of New Ultrasonographic Criteria for CPP Identification in the Joints 221
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 220
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 220
Clodronate: New directions of use 219
Prognostic bioindicators in severe COVID-19 patients 219
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 218
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 217
SAT0542 The Prevalence of Calcium Pyrophosphate Deposits at Ultrasound Examination: Retrospective Analysis in A Cohort of Patients 216
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 215
Serial KL-6 measurements in COVID-19 patients 215
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 214
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 214
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 214
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 214
Comment on: longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica. 212
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 210
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 209
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 208
Evidences for antinociceptive effect of 17-alpha-hydroxyprogesterone caproate in carpal tunnel syndrome 207
Biological treatments in Behçet's disease: beyond anti-TNF therapy 207
Totale 27.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 220.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.757 0 0 0 0 0 826 236 798 491 503 400 503
2021/20224.504 384 538 307 350 262 177 196 202 273 462 477 876
2022/20235.463 365 434 687 726 439 1.083 253 442 509 152 221 152
2023/20245.248 208 158 482 288 258 1.285 1.571 198 48 137 162 453
2024/202514.695 561 782 1.643 797 1.563 861 733 886 1.088 732 1.433 3.616
2025/202624.698 2.546 5.297 5.048 4.403 6.478 926 0 0 0 0 0 0
Totale 73.499